Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Inhibition of Glial Na+ and K+ Currents by Tamoxifen

Inhibition of Glial Na+ and K+ Currents by Tamoxifen Tamoxifen (tmx) is a non-steroidal triphenylethylene derivative that is predominantly known as a competitive antagonist at the estrogen receptor and is used in the treatment of breast cancer. Recent studies suggest that tamoxifen is also beneficial in the treatment of brain metastases and primary brain tumors. Tmx accumulates in brain and its concentration can be up to 46-fold higher than in serum. Therefore, astrocytes may be exposed to tmx in vivo. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Membrane Biology Springer Journals

Inhibition of Glial Na+ and K+ Currents by Tamoxifen

Loading next page...
 
/lp/springer_journal/inhibition-of-glial-na-and-k-currents-by-tamoxifen-JHAHbMolGX

References (36)

Publisher
Springer Journals
Copyright
Copyright © 2001 by Springer-Verlag New York
Subject
Life Sciences; Biochemistry, general; Human Physiology
ISSN
0022-2631
eISSN
1432-1424
DOI
10.1007/s00232-001-0016-2
Publisher site
See Article on Publisher Site

Abstract

Tamoxifen (tmx) is a non-steroidal triphenylethylene derivative that is predominantly known as a competitive antagonist at the estrogen receptor and is used in the treatment of breast cancer. Recent studies suggest that tamoxifen is also beneficial in the treatment of brain metastases and primary brain tumors. Tmx accumulates in brain and its concentration can be up to 46-fold higher than in serum. Therefore, astrocytes may be exposed to tmx in vivo.

Journal

The Journal of Membrane BiologySpringer Journals

Published: Feb 1, 2014

There are no references for this article.